Cite
HARVARD Citation
Feldman, S. et al. (2018). The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans. Journal of medical economics. pp. 537-541. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Feldman, S. et al. (2018). The budget impact of brodalumab for the treatment of moderate-to-severe plaque psoriasis on US commercial health plans. Journal of medical economics. pp. 537-541. [Online].